Advertisement
Advertisement

NVS

NVS logo

Novartis AG

153.92
USD
Sponsored
-1.16
-0.75%
Apr 02, 14:25 UTC -4
Open

NVS Earnings Reports

Positive Surprise Ratio

NVS beat 24 of 40 last estimates.

60%

Next Report

Date of Next Report
Apr 28, 2026
Estimate for Q1 26 (Revenue/ EPS)
$13.82B
/
$2.15
Implied change from Q4 25 (Revenue/ EPS)
+3.66%
/
+6.44%
Implied change from Q1 25 (Revenue/ EPS)
+4.47%
/
-5.29%

Novartis AG earnings per share and revenue

On Feb 04, 2026, NVS reported earnings of 2.02 USD per share (EPS) for Q4 25, missing the estimate of 2.03 USD, resulting in a -0.17% surprise. Revenue reached 13.34 billion, compared to an expected 14.02 billion, with a -4.90% difference. The market reacted with a +2.04% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 2.15 USD, with revenue projected to reach 13.82 billion USD, implying an increase of 6.44% EPS, and increase of 3.66% in Revenue from the last quarter.
FAQ
For Q4 2025, Novartis AG reported EPS of $2.02, missing estimates by -0.17%, and revenue of $13.34B, -4.9% below expectations.
The stock price moved up 2.04%, changed from $149.86 before the earnings release to $152.91 the day after.
The next earning report is scheduled for Apr 28, 2026.
Based on 4 analysts, Novartis AG is expected to report EPS of $2.15 and revenue of $13.82B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement